Blisse Vakkalagadda

Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa

Blisse Vakkalagadda, Charles Frost, Wonkyung Byon et al. · American Journal of Cardiovascular Drugs · 2016 · 116 citations

Pharmacological Study, Oral Direct Inhibitor, Medicine +5

Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches

M. Fakes, Blisse Vakkalagadda, Feng Qian et al. · International Journal of Pharmaceutics · 2008 · 105 citations

Nanomedicine, Oral Bioavailability, Engineering +10

A first-in-human, phase I study of an oral hedgehog (HH) pathway antagonist, BMS-833923 (XL139), in subjects with advanced or metastatic solid tumors.

Lillian L. Siu, K. Papadopoulos, Steven R. Alberts et al. · Journal of Clinical Oncology · 2010 · 62 citations

Oral Hedgehog, Pathology, Pathway Antagonist +18

Leveraging patient‐centric sampling for clinical drug development and decentralized clinical trials: Promise to reality

Katie F. Maass, Matthew Barfield, Mototsugu Ito et al. · Clinical and Translational Science · 2022 · 46 citations · Full text

Blood Samples, Patient Selection, Clinical Endpoint +23

Phase I Dose-Escalation Study of the Novel Antiandrogen BMS-641988 in Patients with Castration-Resistant Prostate Cancer

Dana E. Rathkopf, Glenn Liu, Michael A. Carducci et al. · Clinical Cancer Research · 2010 · 43 citations · Full text